Home
Krishnaswamy Yeleswaram, Chief Development Officer: Rapport Therapeutics RAPP Sell · Filed 04/14
Trade details
- Type
- Insider sale
- Amount
- $357,816
- Shares · price
- 10,200 sh · $35.08 a share
- Held after
- 266,651 sh
- Trade date
- 26/04/14
- Filed
- 26/04/14
- Days to filing
- 0 days
Sold 3.7% of holdings
- Share of holding sold
- 3.7%
Rapport Therapeutics trades, last 26 weeks
What else happened in Rapport Therapeutics around then
Filed or reported within 30 days of the trade day · 03/15~05/14Krishnaswamy Yeleswaram's recent trades
- Krishnaswamy Yeleswaram
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 planRapport Therapeutics
RAPP
$1.8M
37,000 sh
$1.8M
Filed 08/25
Traded 08/25
- Krishnaswamy Yeleswaram
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 planRapport Therapeutics
RAPP
$553.4K
11,472 sh
$553.4K
Filed 08/24
Traded 08/24
- Krishnaswamy Yeleswaram
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 planRapport Therapeutics
RAPP
$102.5K
2,092 sh
$102.5K
Filed 08/19
Traded 08/19
- Krishnaswamy Yeleswaram
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 planRapport Therapeutics
RAPP
$808.8K
20,225 sh
$808.8K
Filed 04/21
Traded 04/17
- Krishnaswamy Yeleswaram
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 planRapport Therapeutics
RAPP
$799.7K
20,225 sh
$799.7K
Filed 04/17
Traded 04/17